Cyclic ADP-ribose | CAS#119340-53-3 | Pyridine nucleotide calcium mobilizer

MedKoo Cat#: 463282 | Name: Cyclic ADP-ribose

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cyclic ADP-ribose is a pyridine nucleotide that mobilizes calcium. It is synthesized from nicotinamide adenine dinucleotide (NAD) by ADP RIBOSE CYCLASE.

Chemical Structure

Cyclic ADP-ribose

CAS#119340-53-3

Theoretical Analysis

MedKoo Cat#: 463282

Name: Cyclic ADP-ribose

CAS#: 119340-53-3

Chemical Formula: C15H21N5O13P2

Exact Mass: 541.0611

Molecular Weight: 541.30

Elemental Analysis: C, 33.28; H, 3.91; N, 12.94; O, 38.42; P, 11.44

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Cyclic ADP-ribose; Cyclic ADP ribose; cADPR; cAPD ribose; E-NAD; ENAD; E NAD; Enzyme-activated NAD; Enzyme activated NAD;

IUPAC/Chemical Name

Adenosine 5'-(trihydrogen diphosphate), N-alpha-D-ribofuranosyl-, intramol. 5'-5'-ester

InChi Key

BQOHYSXSASDCEA-KEOHHSTQSA-N

InChi Code

InChI=1S/C15H21N5O13P2/c16-12-7-13-18-4-19(12)14-10(23)8(21)5(31-14)1-29-34(25,26)33-35(27,28)30-2-6-9(22)11(24)15(32-6)20(13)3-17-7/h3-6,8-11,14-16,21-24H,1-2H2,(H,25,26)(H,27,28)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1

SMILES Code

O=P(OP(O)(OC[C@@H]1[C@@H](O)[C@@H](O)[C@H]2O1)=O)(O)OC[C@H]3O[C@@H]([N@@](C=N4)C5=C4C([N@]2C=N5)=N)[C@H](O)[C@@H]3O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 541.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Chiba Y, Matsumoto M, Hanazaki M, Sakai H. Downregulation of miR-140-3p Contributes to Upregulation of CD38 Protein in Bronchial Smooth Muscle Cells. Int J Mol Sci. 2020 Oct 27;21(21):E7982. doi: 10.3390/ijms21217982. PMID: 33121100. 2: Evans AM. On a Magical Mystery Tour with 8-Bromo-Cyclic ADP-Ribose: From All- or-None Block to Nanojunctions and the Cell-Wide Web. Molecules. 2020 Oct 16;25(20):4768. doi: 10.3390/molecules25204768. PMID: 33081414; PMCID: PMC7587525. 3: Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, Li C, Shen G, Zou B. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther. 2020 Oct 7;5(1):227. doi: 10.1038/s41392-020-00311-7. PMID: 33028824; PMCID: PMC7539288. 4: Omer A, Barrera MC, Moran JL, Lian XJ, Di Marco S, Beausejour C, Gallouzi IE. G3BP1 controls the senescence-associated secretome and its impact on cancer progression. Nat Commun. 2020 Oct 5;11(1):4979. doi: 10.1038/s41467-020-18734-9. PMID: 33020468; PMCID: PMC7536198. 5: Virdi RS, Bavisotto RV, Hopper NC, Vuksanovic N, Melkonian TR, Silvaggi NR, Frick DN. Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3. SLAS Discov. 2020 Sep 28:2472555220960428. doi: 10.1177/2472555220960428. Epub ahead of print. PMID: 32981460. 6: Fliegert R, Riekehr WM, Guse AH. Does Cyclic ADP-Ribose (cADPR) Activate the Non-selective Cation Channel TRPM2? Front Immunol. 2020 Aug 11;11:2018. doi: 10.3389/fimmu.2020.02018. PMID: 32903769; PMCID: PMC7438885. 7: Xu W, Li L, Zhang L. NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death. Front Physiol. 2020 Aug 13;11:901. doi: 10.3389/fphys.2020.00901. PMID: 32903597; PMCID: PMC7438569. 8: Kang BE, Choi JY, Stein S, Ryu D. Implications of NAD+ boosters in translational medicine. Eur J Clin Invest. 2020 Oct;50(10):e13334. doi: 10.1111/eci.13334. Epub 2020 Jul 22. PMID: 32594513. 9: Gerasimenko M, Cherepanov SM, Furuhara K, Lopatina O, Salmina AB, Shabalova AA, Tsuji C, Yokoyama S, Ishihara K, Brenner C, Higashida H. Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder. Sci Rep. 2020 Jun 22;10(1):10035. doi: 10.1038/s41598-019-57236-7. PMID: 32572044; PMCID: PMC7308284. 10: Kincaid JW, Berger NA. NAD metabolism in aging and cancer. Exp Biol Med (Maywood). 2020 Nov;245(17):1594-1614. doi: 10.1177/1535370220929287. Epub 2020 Jun 5. PMID: 32500741. 11: Guedes AG, Dileepan M, Jude JA, Deshpande DA, Walseth TF, Kannan MS. Role of CD38/cADPR signaling in obstructive pulmonary diseases. Curr Opin Pharmacol. 2020 Apr;51:29-33. doi: 10.1016/j.coph.2020.04.007. Epub 2020 May 29. PMID: 32480246; PMCID: PMC7529733. 12: Li JP, Wei W, Li XX, Xu M. Regulation of NLRP3 inflammasome by CD38 through cADPR-mediated Ca2+ release in vascular smooth muscle cells in diabetic mice. Life Sci. 2020 Aug 15;255:117758. doi: 10.1016/j.lfs.2020.117758. Epub 2020 May 11. PMID: 32407845. 13: Tolomeo S, Chiao B, Lei Z, Chew SH, Ebstein RP. A Novel Role of CD38 and Oxytocin as Tandem Molecular Moderators of Human Social Behavior. Neurosci Biobehav Rev. 2020 Aug;115:251-272. doi: 10.1016/j.neubiorev.2020.04.013. Epub 2020 Apr 28. PMID: 32360414. 14: Marchetta P, Möhrle D, Eckert P, Reimann K, Wolter S, Tolone A, Lang I, Wolters M, Feil R, Engel J, Paquet-Durand F, Kuhn M, Knipper M, Rüttiger L. Guanylyl Cyclase A/cGMP Signaling Slows Hidden, Age- and Acoustic Trauma-Induced Hearing Loss. Front Aging Neurosci. 2020 Apr 9;12:83. doi: 10.3389/fnagi.2020.00083. PMID: 32327991; PMCID: PMC7160671. 15: Karanam G, Arumugam MK. Reactive oxygen species generation and mitochondrial dysfunction for the initiation of apoptotic cell death in human hepatocellular carcinoma HepG2 cells by a cyclic dipeptide Cyclo(-Pro-Tyr). Mol Biol Rep. 2020 May;47(5):3347-3359. doi: 10.1007/s11033-020-05407-5. Epub 2020 Apr 4. PMID: 32248385. 16: Guo YS, Xu XF, Li N, Sun N, Duan LF. [Gene expression profiles in normal human prostate epithelial cells exposed to low-dose cadmium: A bioinformatics analysis]. Zhonghua Nan Ke Xue. 2019 Feb;25(2):103-109. Chinese. PMID: 32216194. 17: Shuto S. [Medicinal Chemical Studies Based on the Theoretical Design of Bioactive Compounds]. Yakugaku Zasshi. 2020;140(3):329-344. Japanese. doi: 10.1248/yakushi.19-00208. PMID: 32115550. 18: Ishiwata-Endo H, Kato J, Stevens LA, Moss J. ARH1 in Health and Disease. Cancers (Basel). 2020 Feb 19;12(2):479. doi: 10.3390/cancers12020479. PMID: 32092898; PMCID: PMC7072381. 19: Mahmuda NA, Yokoyama S, Munesue T, Hayashi K, Yagi K, Tsuji C, Higashida H. One Single Nucleotide Polymorphism of the TRPM2 Channel Gene Identified as a Risk Factor in Bipolar Disorder Associates with Autism Spectrum Disorder in a Japanese Population. Diseases. 2020 Feb 7;8(1):4. doi: 10.3390/diseases8010004. PMID: 32046066; PMCID: PMC7151227. 20: Joe Y, Chen Y, Park J, Kim HJ, Rah SY, Ryu J, Cho GJ, Choi HS, Ryter SW, Park JW, Kim UH, Chung HT. Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis. Cell Rep. 2020 Jan 28;30(4):1063-1076.e5. doi: 10.1016/j.celrep.2019.12.090. PMID: 31995750.